These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22521594)
41. Association of paraoxonase-1 gene polymorphisms with insulin resistance in South Indian population. Gomathi P; Iyer AC; Murugan PS; Sasikumar S; Raj NBAJ; Ganesan D; Nallaperumal S; Murugan M; Selvam GS Gene; 2018 Apr; 650():55-59. PubMed ID: 29409844 [TBL] [Abstract][Full Text] [Related]
42. The effect of Çınar E; Akgöllü E; Yücebilgiç G; Bilgin R; Paydaş S Nucleosides Nucleotides Nucleic Acids; 2022; 41(5-6):489-502. PubMed ID: 35306973 [TBL] [Abstract][Full Text] [Related]
43. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Kordi-Tamandani DM; Hashemi M; Sharifi N; Kaykhaei MA; Torkamanzehi A Mol Biol Rep; 2012 Feb; 39(2):937-43. PubMed ID: 21573798 [TBL] [Abstract][Full Text] [Related]
44. Q192R paraoxonase1 polymorphism is a risk factor for cataract in Pakistani population. Baig A; Zohaib M; Rehman AU; Zarina S Pak J Pharm Sci; 2016 May; 29(3):765-71. PubMed ID: 27166546 [TBL] [Abstract][Full Text] [Related]
45. The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis. Wu C; Wu D; Lin M; Zhong Y Diabetes Ther; 2018 Aug; 9(4):1669-1688. PubMed ID: 29987647 [TBL] [Abstract][Full Text] [Related]
46. The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population. Kallel A; Sediri Y; Sbaï MH; Mourali MS; Feki M; Elasmi M; Taieb SH; Sanhaji H; Souheil O; Mechmeche R; Jemaa R; Kaabachi N Clin Biochem; 2010 Dec; 43(18):1461-3. PubMed ID: 20833162 [TBL] [Abstract][Full Text] [Related]
47. Association between PON1 L55M polymorphism and ischemic stroke: a systematic review and meta-analysis. Shao P; Qu DJ; Song RY; Chen ML; Wang LH Int J Clin Exp Med; 2015; 8(3):3429-37. PubMed ID: 26064233 [TBL] [Abstract][Full Text] [Related]
48. Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes. Mahrooz A; Hashemi-Soteh MB; Heydari M; Boorank R; Ramazani F; Mahmoudi A; Kianmehr A; Alizadeh A Clin Chim Acta; 2018 Sep; 484():40-46. PubMed ID: 29782842 [TBL] [Abstract][Full Text] [Related]
49. Association between paraoxonase-1 gene Q192R and L55M polymorphisms and risk of gastric cancer: A case-control study from Iran. Hemati M; Mansourabadi AH; Bafghi MK; Moradi A Nucleosides Nucleotides Nucleic Acids; 2019; 38(7):521-532. PubMed ID: 30857497 [TBL] [Abstract][Full Text] [Related]
50. Paraoxonase 1 gene (Q192R) polymorphism confers susceptibility to coronary artery disease in type 2 diabetes patients: Evidence from case-control studies. Huo X; Guo Y; Zhang Y; Li J; Wen X; Liu J Drug Discov Ther; 2019; 13(2):80-88. PubMed ID: 31080207 [TBL] [Abstract][Full Text] [Related]
51. Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt. Ibrahim AA; El-Lebedy D; Ashmawy I; Hady MA Clin Rheumatol; 2017 Jun; 36(6):1305-1310. PubMed ID: 28185016 [TBL] [Abstract][Full Text] [Related]
52. Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients. Martínez-Salazar MF; Soriano-Martínez ML; Juantorena-Ugas A; Almenares-López D; Yescas P; Boll MC; Monroy-Noyola A Colomb Med (Cali); 2018 Sep; 49(3):223-227. PubMed ID: 30410197 [TBL] [Abstract][Full Text] [Related]
53. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin. Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287 [TBL] [Abstract][Full Text] [Related]
54. PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations. Chen H; Ding S; Zhou M; Wu X; Liu X; Liu J; Wu Y; Liu D Herz; 2018 Nov; 43(7):642-648. PubMed ID: 28835968 [TBL] [Abstract][Full Text] [Related]
55. Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia. Tomatir AG; Pehlivan S; Sahin HH; Balci SO; Budeyri S; Pehlivan M Anticancer Res; 2015 Sep; 35(9):4807-12. PubMed ID: 26254371 [TBL] [Abstract][Full Text] [Related]
56. Association of Godbole C; Thaker S; Kerkar P; Nadkar M; Gogtay N; Thatte U Future Cardiol; 2021 Jan; 17(1):119-126. PubMed ID: 32583675 [No Abstract] [Full Text] [Related]
57. The Role of Paraoxonase 1 (PON1) Gene Polymorphisms in Coronary Artery Disease: A Systematic Review and Meta-Analysis. Ashiq S; Ashiq K Biochem Genet; 2021 Aug; 59(4):919-939. PubMed ID: 33599870 [TBL] [Abstract][Full Text] [Related]
58. Genetic variation at Q192R and L55M polymorphisms in PON1. Mitra S; Kshatriya GK Environ Toxicol Pharmacol; 2016 Jul; 45():251-6. PubMed ID: 27341351 [TBL] [Abstract][Full Text] [Related]
59. Paraoxonase 1 status in the Thai population. Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216 [TBL] [Abstract][Full Text] [Related]
60. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies. Wang M; Lang X; Zou L; Huang S; Xu Z Atherosclerosis; 2011 Feb; 214(2):377-85. PubMed ID: 21146823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]